This study conducted a network meta-analysis to evaluate and rank the safety and efficacy of different treatment regimens for untreated advanced GC, specifically comparing PD-1 inhibitor monotherapy, chemotherapy, and PD-1 inhibitors plus chemotherapy. Here, PDCD1 is linked to gastric cancer.